Medications

New paper calls for strong steps to tackle antibiotic resistance

Shahriar Mobashery, a University of Notre Dame researcher, is one of the coauthors of a new paper by a group of the world's leading scientists in academia and industry that calls for strong steps to be taken to control the ...

Diseases, Conditions, Syndromes

Vaccine hopes and economic woes as virus spreads

President Donald Trump voiced hope Friday that a coronavirus vaccine will be available by late 2020, cushioning dire US economic news as parts of Europe re-open despite fears of a second wave of the pandemic.

Diseases, Conditions, Syndromes

Young, but vulnerable to COVID-19

Although populations in countries in the Global South are on average younger than in Europe, they might be more vulnerable to severe forms of COVID-19. One reason for this is the higher proportion of people at working age ...

Diseases, Conditions, Syndromes

Preventing the next pandemic

Thus far, COVID-19 has cost at least $2.6 trillion and may cost ten times this amount. It is the largest global pandemic in 100 years. Six months after emerging, it has killed over 600,000 people and is having a major impact ...

page 5 from 40